Oncoclinicas do Brasil (ONCO3) - Total Liabilities

Latest as of September 2025: R$7.02 Billion BRL ≈ $1.38 Billion USD

Based on the latest financial reports, Oncoclinicas do Brasil (ONCO3) has total liabilities worth R$7.02 Billion BRL (≈ $1.38 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Oncoclinicas do Brasil (ONCO3) net asset momentum to track the company's year-over-year net asset growth rate.

Oncoclinicas do Brasil - Total Liabilities Trend (2013–2024)

This chart illustrates how Oncoclinicas do Brasil's total liabilities have evolved over time, based on quarterly financial data.

Oncoclinicas do Brasil Competitors by Total Liabilities

The table below lists competitors of Oncoclinicas do Brasil ranked by their total liabilities.

Company	Country	Total Liabilities
CyberTAN Technology Inc TW:3062	Taiwan	NT$2.05 Billion
WITHSECURE HE:WITH	Finland	€99.79 Million
Humasis Co. Ltd KQ:205470	Korea	₩90.75 Billion
Arvind SmartSpaces Limited NSE:ARVSMART	India	Rs19.07 Billion
Goodrx Holdings Inc NASDAQ:GDRX	USA	$724.79 Million
Korea Environment Technology Co. LTD KQ:029960	Korea	₩53.13 Billion
Bus Online Co Ltd SHE:002188	China	CN¥223.64 Million
Cybin Inc NEO:CYBN	Canada	CA$16.18 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Oncoclinicas do Brasil's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Oncoclinicas do Brasil stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.12	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.06	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	7.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.85	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oncoclinicas do Brasil's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oncoclinicas do Brasil (2013–2024)

The table below shows the annual total liabilities of Oncoclinicas do Brasil from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	R$7.82 Billion ≈ $1.53 Billion	+20.27%
2023-12-31	R$6.50 Billion ≈ $1.28 Billion	+16.37%
2022-12-31	R$5.59 Billion ≈ $1.10 Billion	+49.90%
2021-12-31	R$3.73 Billion ≈ $731.40 Million	+37.43%
2020-12-31	R$2.71 Billion ≈ $532.20 Million	+86.55%
2019-12-31	R$1.45 Billion ≈ $285.28 Million	+65.56%
2018-12-31	R$878.19 Million ≈ $172.32 Million	+58.52%
2017-12-31	R$553.99 Million ≈ $108.70 Million	+47.92%
2016-12-31	R$374.51 Million ≈ $73.49 Million	+14.68%
2015-12-31	R$326.58 Million ≈ $64.08 Million	-3.43%
2014-12-31	R$338.17 Million ≈ $66.35 Million	+24.20%
2013-12-31	R$272.27 Million ≈ $53.43 Million	--

About Oncoclinicas do Brasil

SA:ONCO3 Brazil Medical Care Facilities

Market Cap

$301.69 Million

R$1.54 Billion BRL

Market Cap Rank

#15006 Global

#143 in Brazil

Share Price

R$1.75

Change (1 day)

+19.86%

52-Week Range

R$1.04 - R$5.72

All Time High

R$19.24